 HEIDELBERG, Germany, Nov. 01, 2022 GLOBE NEWSWIRE -- Affimed N.V. Nasdaq: AFMD Affimed, or the Company, a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its Chief Executive Officer, Dr. Adi Hoess, will present at the 2022 Jefferies London Healthcare Conference on Wednesday, November 16, 2022, at 12:55 p.m. GMT 7:55 a.m. EST 13:55 CET. 